Utah Medical Products Statistics
Total Valuation
UTMD has a market cap or net worth of $229.33 million. The enterprise value is $144.31 million.
| Market Cap | 229.33M |
| Enterprise Value | 144.31M |
Important Dates
The last earnings date was Thursday, October 22, 2026, before market open.
| Earnings Date | Oct 22, 2026 |
| Ex-Dividend Date | Dec 17, 2026 |
Share Statistics
UTMD has 3.18 million shares outstanding. The number of shares has decreased by -3.07% in one year.
| Current Share Class | 3.18M |
| Shares Outstanding | 3.18M |
| Shares Change (YoY) | -3.07% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 7.22% |
| Owned by Institutions (%) | 69.60% |
| Float | 2.77M |
Valuation Ratios
The trailing PE ratio is 21.63.
| PE Ratio | 21.63 |
| Forward PE | n/a |
| PS Ratio | 6.57 |
| Forward PS | n/a |
| PB Ratio | 1.86 |
| P/TBV Ratio | 2.18 |
| P/FCF Ratio | 20.03 |
| P/OCF Ratio | 19.36 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.78, with an EV/FCF ratio of 12.61.
| EV / Earnings | 13.56 |
| EV / Sales | 4.13 |
| EV / EBITDA | 10.78 |
| EV / EBIT | 12.06 |
| EV / FCF | 12.61 |
Financial Position
The company has a current ratio of 21.23, with a Debt / Equity ratio of 0.00.
| Current Ratio | 21.23 |
| Quick Ratio | 18.81 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.81% and return on invested capital (ROIC) is 26.90%.
| Return on Equity (ROE) | 8.81% |
| Return on Assets (ROA) | 5.97% |
| Return on Invested Capital (ROIC) | 26.90% |
| Return on Capital Employed (ROCE) | 9.67% |
| Weighted Average Cost of Capital (WACC) | 6.50% |
| Revenue Per Employee | $229,724 |
| Profits Per Employee | $70,020 |
| Employee Count | 152 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.58 |
Taxes
In the past 12 months, UTMD has paid $2.33 million in taxes.
| Income Tax | 2.33M |
| Effective Tax Rate | 17.98% |
Stock Price Statistics
The stock price has increased by +24.53% in the last 52 weeks. The beta is 0.41, so UTMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +24.53% |
| 50-Day Moving Average | 72.89 |
| 200-Day Moving Average | 68.31 |
| Relative Strength Index (RSI) | 49.73 |
| Average Volume (20 Days) | 39,013 |
Short Selling Information
The latest short interest is 140,215, so 4.42% of the outstanding shares have been sold short.
| Short Interest | 140,215 |
| Short Previous Month | 151,912 |
| Short % of Shares Out | 4.42% |
| Short % of Float | 5.06% |
| Short Ratio (days to cover) | 3.76 |
Income Statement
In the last 12 months, UTMD had revenue of $34.92 million and earned $10.64 million in profits. Earnings per share was $3.34.
| Revenue | 34.92M |
| Gross Profit | 20.14M |
| Operating Income | 11.97M |
| Pretax Income | 12.98M |
| Net Income | 10.64M |
| EBITDA | 13.39M |
| EBIT | 11.97M |
| Earnings Per Share (EPS) | $3.34 |
Balance Sheet
The company has $85.20 million in cash and $180,000 in debt, with a net cash position of $85.02 million or $26.78 per share.
| Cash & Cash Equivalents | 85.20M |
| Total Debt | 180,000 |
| Net Cash | 85.02M |
| Net Cash Per Share | $26.78 |
| Equity (Book Value) | 123.28M |
| Book Value Per Share | 38.83 |
| Working Capital | 95.89M |
Cash Flow
In the last 12 months, operating cash flow was $11.85 million and capital expenditures -$400,000, giving a free cash flow of $11.45 million.
| Operating Cash Flow | 11.85M |
| Capital Expenditures | -400,000 |
| Depreciation & Amortization | 1.42M |
| Net Borrowing | n/a |
| Free Cash Flow | 11.45M |
| FCF Per Share | $3.61 |
Margins
Gross margin is 57.69%, with operating and profit margins of 34.27% and 30.48%.
| Gross Margin | 57.69% |
| Operating Margin | 34.27% |
| Pretax Margin | 37.16% |
| Profit Margin | 30.48% |
| EBITDA Margin | 38.34% |
| EBIT Margin | 34.27% |
| FCF Margin | 31.70% |
Dividends & Yields
This stock pays an annual dividend of $1.26, which amounts to a dividend yield of 1.74%.
| Dividend Per Share | $1.26 |
| Dividend Yield | 1.74% |
| Dividend Growth (YoY) | 1.63% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 37.74% |
| FCF Payout Ratio | 34.95% |
| Buyback Yield | 3.07% |
| Shareholder Yield | 4.82% |
| Earnings Yield | 4.62% |
| FCF Yield | 4.99% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on March 22, 1993. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 22, 1993 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |